0 NYSE Companies - May 14, 2020Brookfield Asset Management Announces Dividend Declaration and Reports First Quarter 2020 ResultsBROOKFIELD, News, May 14, 2020 (GLOBE NEWSWIRE) — Brookfield Asset Management Inc. (NYSE: BAM, TSX: BAM.A) today announced financial results […]Read More
0 NYSE Companies - May 14, 2020Endeavour Silver Announces At-The-Market Offering of up to US$23 MillionVANCOUVER, British Columbia, May 14, 2020 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (NYSE: EXK, TSX: EDR) (the “Company” or “Endeavour”) […]Read More
0 NYSE Companies - May 14, 2020TransUnion Declares First Quarter 2020 Dividend of $0.075 per ShareCHICAGO, May 14, 2020 (GLOBE NEWSWIRE) — TransUnion (NYSE: TRU) today announced that its Board of Directors declared a cash […]Read More
0 NASDAQ Companies - May 14, 2020Iterum Therapeutics Reports First Quarter 2020 Financial Results–Phase 3 topline results from sulopenem clinical trials in uUTI and cUTI expected Q2 —— Raised $51.6 million through a […]Read More
0 NASDAQ Companies - May 14, 2020TCR² Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate UpdateContinued progress on treatment of TC-210 patients with interim update from Phase 1 portion of Phase 1/2 clinical trial anticipated […]Read More
0 TSX News - May 14, 2020Bombardier’s FLEXITY high-floor trams authorized for the Düsseldorf networkModern FLEXITY trams have achieved authorization to operate in the Düsseldorf metropolitan areaThe new generation of FLEXITY trams are energy […]Read More
0 TSX News - May 14, 2020MediPharm Labs Signs Wide-Ranging Strategic Manufacturing and IP Licensing Agreement with Biopharmaceutical Leader Avicanna Inc.BARRIE, Ontario, May 14, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or […]Read More
0 NYSE Companies - May 14, 2020InfuSystem Holdings, Inc. Reports First Quarter 2020 Financial ResultsROCHESTER HILLS, Michigan, May 14, 2020 (GLOBE NEWSWIRE) — InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company”), a […]Read More
0 NASDAQ Companies - May 14, 2020Kaleido Biosciences Provides Corporate Update and Reports First Quarter 2020 Financial Results– Initiating Clinical Studies of KB109 in Outpatients with Mild-to-Moderate COVID-19; Data Anticipated in Q4 2020 –– Expanding Work in […]Read More
0 NASDAQ Companies - May 14, 2020Kaleido Biosciences Initiates Controlled Clinical Study of Microbiome Metabolic Therapy KB109 in Outpatients with Mild-to-Moderate COVID-19– Top-Line Data from Study of Approximately 350 Patients Expected in Q4 2020 – – Second Clinical Study [...]Read More